Instil Bio (TIL)
(Delayed Data from NSDQ)
$11.88 USD
+0.08 (0.68%)
Updated May 14, 2024 04:00 PM ET
After-Market: $11.84 -0.04 (-0.34%) 7:58 PM ET
2-Buy of 5 2
F Value A Growth D Momentum C VGM
Price, Consensus and EPS Surprise
TIL 11.88 +0.08(0.68%)
Will TIL be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for TIL based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for TIL
What Makes Instil Bio (TIL) a New Buy Stock
Instil (TIL) Stock Rises More Than 20% in a Week: Here's Why
TIL: What are Zacks experts saying now?
Zacks Private Portfolio Services
After Plunging -18.52% in 4 Weeks, Here's Why the Trend Might Reverse for Instil Bio, Inc. (TIL)
Down 61.6% in 4 Weeks, Here's Why You Should You Buy the Dip in Instil Bio, Inc. (TIL)
Down 59.5% in 4 Weeks, Here's Why You Should You Buy the Dip in Instil Bio, Inc. (TIL)
Other News for TIL
Instil Bio price target lowered by $22 at Baird, here's why
Analysts Offer Insights on Healthcare Companies: ANI Pharmaceuticals (ANIP), Fate Therapeutics (FATE) and Instil Bio (TIL)
TIL Stock Earnings: Instil Bio Misses EPS for Q1 2024
Instil Bio reports Q1 results
Instil Bio Reports First Quarter 2024 Financial Results and Provides Corporate Update